AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity

Nucleic Acids Research

Volumn 37, Issue 6, 2009, Pages 1854-1867

  Macduff, Donna A ^a   Demorest, Zachary L ^a   Harris, Reuben S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; DNA;

ADAPTIVE IMMUNITY; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOPLASM; DEAMINATION; FEMALE; FUNGUS IMMUNITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RETROPOSON; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL NUCLEUS; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; LONG INTERSPERSED REPEAT; METABOLISM; MOLECULAR GENETICS; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; RAT; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; VERTEBRATE; YEAST;

MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY DIVERSITY; CELL LINE; CELL NUCLEUS; CYTIDINE DEAMINASE; DNA; ESCHERICHIA COLI; HUMANS; IMMUNITY, INNATE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; RATS; RETROELEMENTS; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; VERTEBRATES; YEASTS;

EID: 64549103299     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp030     Document Type: Article

References (97)

1. Dickerson,S.K., Market,E., Besmer,E. and Papavasiliou,F.N. (2003) AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med., 197, 1291-1296.
2. Chaudhuri,J., Tian,M., Khuong,C., Chua,K., Pinaud,E. and Alt,F.W. (2003) Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature, 422, 726-730.
3. Bransteitter,R., Pham,P., Scharff,M.D. and Goodman,M.F. (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl Acad. Sci. USA, 100, 4102-4107.
4. Petersen-Mahrt,S.K., Harris,R.S. and Neuberger,M.S. (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature, 418, 99-103.
5. Harris,R.S., Sale,J.E., Petersen-Mahrt,S.K. and Neuberger,M.S. (2002) AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol., 12, 435-438.
6. Arakawa,H., Hauschild,J. and Buerstedde,J.M. (2002) Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science, 295, 1301-1306.
7. Revy,P., Muto,T., Levy,Y., Geissmann,F., Plebani,A., Sanal,O., Catalan,N., Forveille,M., Dufourcq-Labelouse,R., Gennery,A. et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell, 102, 565-575.
8. Muramatsu,M., Kinoshita,K., Fagarasan,S., Yamada,S., Shinkai,Y. and Honjo,T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102, 553-563.
9. Minegishi,Y., Lavoie,A., Cunningham-Rundles,C., Bedard,P.M., Hebert,J., Cote,L., Dan,K., Sedlak,D., Buckley,R.H., Fischer,A. et al. (2000) Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin. Immunol., 97, 203-210.
10. Cannon,J.P., Haire,R.N., Rast,J.P. and Litman,G.W. (2004) The phylogenetic origins of the antigen-binding receptors and somatic diversification mechanisms. Immunol. Rev., 200, 12-22.
11. Mussmann,R., Wilson,M., Marcuz,A., Courtet,M. and Du Pasquier,L. (1996) Membrane exon sequences of the three Xenopus Ig classes explain the evolutionary origin of mammalian isotypes. Eur. J. Immunol., 26 409-414.
12. Greenberg,A.S., Avila,D., Hughes,M., Hughes,A., McKinney,E.C. and Flajnik,M.F. (1995) A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374, 168-173.
13. Hinds-Frey,K.R., Nishikata,H., Litman,R.T. and Litman,G.W. (1993) Somatic variation precedes extensive diversification of germline sequences and combinatorial joining in the evolution of immunoglobulin heavy chain diversity. J. Exp. Med., 178, 815-824.
14. Chiu,Y.L. and Greene,W.C. (2008) The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol., 26, 317-353.
15. Malim,M.H. and Emerman,M. (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe, 3, 388-398.
16. Schumacher,A.J., Haché,G., Macduff,D.A., Brown,W.L. and Harris,R.S. (2008) The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82, 2652-2660.
17. Miyagi,E., Opi,S., Takeuchi,H., Khan,M., Goila-Gaur,R., Kao,S. and Strebel,K. (2007) Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1. J. Virol., 81, 13346-13353.
18. Zhang,H., Yang,B., Pomerantz,R.J., Zhang,C., Arunachalam,S.C. and Gao,L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature, 424, 94-98.
19. Harris,R.S., Bishop,K.N., Sheehy,A.M., Craig,H.M., Petersen-Mahrt, S.K., Watt,I.N., Neuberger,M.S. and Malim,M.H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell, 113, 803-809.
20. Sheehy,A.M., Gaddis,N.C., Choi,J.D. and Malim,M.H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature, 418, 646-650.
21. Holmes,R.K., Koning,F.A., Bishop,K.N. and Malim,M.H. (2007) APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282, 2587-2595.
22. Stenglein,M.D. and Harris,R.S. (2006) APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem., 281, 16837-16841.
23. Muckenfuss,H., Hamdorf,M., Held,U., Perkovic,M., Lower,J., Cichutek,K., Flory,E., Schumann,G.G. and Munk,C. (2006) APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem., 281, 22161-22172.
24. Chiu,Y.L., Witkowska,H.E., Hall,S.C., Santiago,M., Soros,V.B., Esnault,C., Heidmann,T. and Greene,W.C. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl Acad. Sci. USA, 103, 15588-15593.
25. Bogerd,H.P., Wiegand,H.L., Hulme,A.E., Garcia-Perez,J.L., O'Shea,K.S., Moran,J.V. and Cullen,B.R. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl Acad. Sci. USA, 103, 8780-8785.
26. Schumacher,A.J., Nissley,D.V. and Harris,R.S. (2005) APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl Acad. Sci. USA, 102, 9854-9859.
27. Esnault,C., Heidmann,O., Delebecque,F., Dewannieux,M., Ribet,D., Hance,A.J., Heidmann,T. and Schwartz,O. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature, 433, 430-433.
28. Dutko,J.A., Schafer,A., Kenny,A.E., Cullen,B.R. and Curcio,M.J. (2005) Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol., 15, 661-666.
29. OhAinle,M., Kerns,J.A., Li,M.M., Malik,H.S. and Emerman,M. (2008) Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe, 4, 249-259.
30. Niewiadomska,A.M., Tian,C., Tan,L., Wang,T., Sarkis,P.T. and Yu,X.F. (2007) Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecularmass-complex formation or P-body association. J. Virol., 81, 9577-9583.
31. Kinomoto,M., Kanno,T., Shimura,M., Ishizaka,Y., Kojima,A., Kurata,T., Sata,T. and Tokunaga,K. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955-2964.
32. Chen,H., Lilley,C.E., Yu,Q., Lee,D.V., Chou,J., Narvaiza,I., Landau,N.R. and Weitzman,M.D. (2006) APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol., 16 480-485.
33. Hulme,A.E., Bogerd,H.P., Cullen,B.R. and Moran,J.V. (2007) Selective inhibition of Alu retrotransposition by APOBEC3G. Gene, 390, 199-205.
34. Turelli,P., Vianin,S. and Trono,D. (2004) The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J. Biol. Chem., 279, 43371-43373.
35. Esnault,C., Millet,J., Schwartz,O. and Heidmann,T. (2006) Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res., 34, 1522-1531.
36. Esnault,C., Priet,S., Ribet,D., Heidmann,O. and Heidmann,T. (2008) Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: Ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements. Retrovirology, 5, 75.
37. Jern,P., Stoye,J.P. and Coffin,J.M. (2007) Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet., 3, 2014-2022.
38. Lee,Y.N., Malim,M.H. and Bieniasz,P.D. (2008) Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol., 82, 8762-8770.
39. Cost,G.J., Feng,Q., Jacquier,A. and Boeke,J.D. (2002) Human L1 element target-primed reverse transcription in vitro. EMBO J., 21, 5899-5910.
40. Luan,D.D., Korman,M.H., Jakubczak,J.L. and Eickbush,T.H. (1993) Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: A mechanism for non-LTR retrotransposition. Cell, 72, 595-605.
41. LaRue,R.S., Jónsson,S.R., Silverstein,K.A.T., Lajoie,M., Bertrand,D., El-Mabrouk,N., Hötzel,I., Andrésdóttir,V., Timothy,P.L., Smith,T.P.L. et al. (2008) The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol., 9, 104.
42. Conticello,S.G., Langlois,M.A., Yang,Z. and Neuberger,M.S. (2007) DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv. Immunol., 94, 37-73.
43. Conticello,S.G., Thomas,C.J., Petersen-Mahrt,S.K. and Neuberger,M.S. (2005) Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol., 22, 367-377.
44. Harris,R.S. and Liddament,M.T. (2004) Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol., 4, 868-877.
45. Macduff,D.A. and Harris,R.S. (2006) Directed DNA deamination by AID/ APOBEC3 in immunity. Curr Biol, 16, R186-R189.
46. Larkin,M.A., Blackshields,G., Brown,N.P., Chenna,R., McGettigan,P.A., McWilliam,H., Valentin,F., Wallace,I.M., Wilm,A., Lopez,R. et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23 2947-2948.
47. Suyama,M., Torrents,D. and Bork,P. (2006) PAL2NAL: Robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res., 34, W609-W612.
48. Clamp,M., Cuff,J., Searle,S.M. and Barton,G.J. (2004) The Jalview Java alignment editor. Bioinformatics, 20, 426-427.
49. Kosakovsky Pond,S.L., Posada,D., Gravenor,M.B., Woelk,C.H. and Frost,S.D. (2006) GARD: A genetic algorithm for recombination detection. Bioinformatics, 22, 3096-3098.
50. Retief,J.D. (2000) Phylogenetic analysis using PHYLIP. Methods Mol. Biol., 132, 243-258.
51. Uenishi,H., Eguchi,T., Suzuki,K., Sawazaki,T., Toki,D., Shinkai,H., Okumura,N., Hamasima,N. and Awata,T. (2004) PEDE (Pig EST Data Explorer): Construction of a database for ESTs derived from porcine full-length cDNA libraries. Nucleic Acids Res., 32, D484-D488.
52. Buerstedde,J.M. and Takeda,S. (1991) Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67, 179-188.
53. Yu,Q., Chen,D., Konig,R., Mariani,R., Unutmaz,D. and Landau,N.R. (2004) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem., 279, 53379-53386.
54. MacDuff,D.A., Neuberger,M.S. and Harris,R.S. (2006) MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells. Mol. Immunol., 43, 1099-1108.
55. Harris,R.S., Petersen-Mahrt,S.K. and Neuberger,M.S. (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell, 10, 1247-1253.
56. Ichikawa,H.T., Sowden,M.P., Torelli,A.T., Bachl,J., Huang,P., Dance,G.S., Marr,S.H., Robert,J., Wedekind,J.E., Smith,H.C. et al. (2006) Structural phylogenetic analysis of activation-induced deaminase function. J. Immunol., 177, 355-361.
57. Barreto,V.M., Pan-Hammarström,Q., Zhao,Y., Hammarströ m,L., Misulovin,Z. and Nussenzweig,M.C. (2005) AID from bony fish catalyzes class switch recombination. J. Exp. Med., 202, 733-738.
58. Saunders,H.L. and Magor,B.G. (2004) Cloning and expression of the AID gene in the channel catfish. Dev. Comp. Immunol., 28, 657-663.
59. Ostertag,E.M., Prak,E.T., DeBerardinis,R.J., Moran,J.V. and Kazazian,H.H. Jr (2000) Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res., 28, 1418-1423.
60. Chen,K.M., Harjes,E., Gross,P.J., Fahmy,A., Lu,Y., Shindo,K., Harris,R.S. and Matsuo,H. (2008) Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature, 452, 116-119.
61. Rada,C., Jarvis,J.M. and Milstein,C. (2002) AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl Acad. Sci. USA, 99, 7003-7008.
62. McBride,K.M., Barreto,V., Ramiro,A.R., Stavropoulos,P. and Nussenzweig,M.C. (2004) Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med., 199, 1235-1244.
63. Ito,S., Nagaoka,H., Shinkura,R., Begum,N., Muramatsu,M., Nakata,M. and Honjo,T. (2004) Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl Acad. Sci. USA, 101, 1975-1980.
64. Pasqualucci,L., Kitaura,Y., Gu,H. and Dalla-Favera,R. (2006) PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl Acad. Sci. USA, 103, 395-400.
65. Basu,U., Chaudhuri,J., Alpert,C., Dutt,S., Ranganath,S., Li,G., Schrum,J.P., Manis,J.P. and Alt,F.W. (2005) The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature, 438, 508-511.
66. McBride,K.M., Gazumyan,A., Woo,E.M., Schwickert,T.A., Chait,B.T. and Nussenzweig,M.C. (2008) Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med., 205, 2585-2594.
67. Chatterji,M., Unniraman,S., McBride,K.M. and Schatz,D.G. (2007) Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation. J. Immunol., 179 5274-5280.
68. McBride,K.M., Gazumyan,A., Woo,E.M., Barreto,V.M., Robbiani,D.F., Chait,B.T. and Nussenzweig,M.C. (2006) Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl Acad. Sci. USA, 103, 8798-8803.
69. Bogerd,H.P., Tallmadge,R.L., Oaks,J.L., Carpenter,S. and Cullen,B.R. (2008) Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J. Virol., 82, 11889-11901.
70. Bogerd,H.P., Wiegand,H.L., Doehle,B.P., Lueders,K.K. and Cullen,B.R. (2006) APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res., 34, 89-95.
71. Armitage,A.E., Katzourakis,A., de Oliveira,T., Welch,J.J., Belshaw,R., Bishop,K.N., Kramer,B., McMichael,A.J., Rambaut,A. and Iversen,A.K. (2008) Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J. Virol., 82, 8743-8761.
72. Jónsson,S.R., LaRue,R.S., Stenglein,M.D., Fahrenkrug,S.C., Andrésdóttir,V. and Harris,R.S. (2007) The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS ONE, 2, e893.
73. Ribet,D., Dewannieux,M. and Heidmann,T. (2004) An active murine transposon family pair: Retrotransposition of "master" MusD copies and ETn trans-mobilization. Genome Res., 14, 2261-2267.
74. Poltoratsky,V.P., Wilson,S.H., Kunkel,T.A. and Pavlov,Y.I. (2004) mbinogenic phenotype of human activation-induced cytosine deaminase. J. Immunol., 172, 4308-4313.
75. Prak,E.T., Dodson,A.W., Farkash,E.A. and Kazazian,H.H. Jr (2003) Tracking an embryonic L1 retrotransposition event. Proc. Natl Acad. Sci. USA, 100, 1832-1837.
76. Ostertag,E.M., DeBerardinis,R.J., Goodier,J.L., Zhang,Y., Yang,N., Gerton,G.L. and Kazazian,H.H. Jr (2002) A mouse model of human L1 retrotransposition. Nat. Genet., 32, 655-660.
77. Brouha,B., Meischl,C., Ostertag,E., de Boer,M., Zhang,Y., Neijens,H., Roos,D. and Kazazian,H.H. Jr (2002) Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am. J. Hum. Genet., 71, 327-336.
78. Maksakova,I.A., Romanish,M.T., Gagnier,L., Dunn,C.A., van de Lagemaat,L.N. and Mager,D.L. (2006) Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet., 2 e2.
79. Matsumoto,Y., Marusawa,H., Kinoshita,K., Endo,Y., Kou,T., Morisawa,T., Azuma,T., Okazaki,I.M., Honjo,T. and Chiba,T. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med., 13, 470-476.
80. Endo,Y., Marusawa,H., Kinoshita,K., Morisawa,T., Sakurai,T., Okazaki,I.M., Watashi,K., Shimotohno,K., Honjo,T. and Chiba,T. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene., 26, 5587-5595.
81. Schreck,S., Buettner,M., Kremmer,E., Bogdan,M., Herbst,H. and Niedobitek,G. (2006) Activation-induced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J. Pathol., 210, 26-31.
82. Morgan,H.D., Dean,W., Coker,H.A., Reik,W. and Petersen-Mahrt,S.K. (2004) Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem., 279, 52353-52360.
83. Wang,X., Dolan,P.T., Dang,Y. and Zheng,Y.H. (2007) Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle. J. Biol. Chem., 282, 1585-1594.
84. Kreisberg,J.F., Yonemoto,W. and Greene,W.C. (2006) Endogenous factors enhance HIV infection of tissue naive CD4T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med., 203 865-870.
85. Chiu,Y.L., Soros,V.B., Kreisberg,J.F., Stopak,K., Yonemoto,W. and Greene,W.C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature, 435, 108-114.
86. Ta,V.T., Nagaoka,H., Catalan,N., Durandy,A., Fischer,A., Imai,K., Nonoyama,S., Tashiro,J., Ikegawa,M., Ito,S. et al. (2003) AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol., 4, 843-848.
87. Conticello,S.G., Ganesh,K., Xue,K., Lu,M., Rada,C. and Neuberger,M.S. (2008) Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol. Cell, 31, 474-484.
88. Han,Y., Wang,X., Dang,Y. and Zheng,Y. H. (2008) APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication. PloS Pathog., 4, e1000095.
89. Kou,T., Marusawa,H., Kinoshita,K., Endo,Y., Okazaki,I.M., Ueda,Y., Kodama,Y., Haga,H., Ikai,I. and Chiba,T. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int. J. Cancer., 120, 469-476.
90. Gourzi,P., Leonova,T. and Papavasiliou,F.N. (2006) A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity, 24, 779-786.
91. Waterston,R.H., Lindblad-Toh,K., Birney,E., Rogers,J., Abril,J.F., Agarwal,P., Agarwala,R., Ainscough,R., Alexandersson,M., An,P. et al (2002) Initial sequencing and comparative analysis of the mouse genome. Nature, 420, 520-562.
92. Lander,E.S., Linton,L.M., Birren,B., Nusbaum,C., Zody,M.C., Baldwin,J., Devon,K., Dewar,K., Doyle,M., FitzHugh,W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
93. Brouha,B., Schustak,J., Badge,R.M., Lutz-Prigge,S., Farley,A.H., Moran,J.V. and Kazazian,H.H. Jr (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA 100, 5280-5285.
94. Goodier,J.L., Ostertag,E.M., Du,K. and Kazazian,H.H. Jr (2001) A novel active L1 retrotransposon subfamily in the mouse. Genome Res., 11, 1677-1685.
95. DeBerardinis,R.J., Goodier,J.L., Ostertag,E.M. and Kazazian,H.H. Jr (1998) Rapid amplification of a retrotransposon subfamily is evolving the mouse genome. Nat. Genet., 20, 288-290.
96. Zhang,J. and Webb,D.M. (2004) Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet., 13, 1785-1791.
97. Sawyer,S.L., Emerman,M. and Malik,H.S. (2004) Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol., 2, E275.